Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
出版年份 2019 全文链接
标题
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
作者
关键词
-
出版物
eLife
Volume 8, Issue -, Pages -
出版商
eLife Sciences Publications, Ltd
发表日期
2019-03-12
DOI
10.7554/elife.44161
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SvABA: genome-wide detection of structural variants and indels by local assembly
- (2018) Jeremiah A. Wala et al. GENOME RESEARCH
- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
- (2018) Giuseppa Augello et al. Cell Death & Disease
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
- (2017) Giannicola Genovese et al. NATURE
- SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters
- (2017) Robert T Nakayama et al. NATURE GENETICS
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases
- (2017) Marcus A. Carden et al. PEDIATRIC BLOOD & CANCER
- Renal medullary carcinoma: A national analysis of 159 patients
- (2017) Brian Ezekian et al. PEDIATRIC BLOOD & CANCER
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
- (2017) Irina Alimova et al. Oncotarget
- Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
- (2017) Wilfrid Richer et al. Oncotarget
- Synthetic Lethal Vulnerabilities in KRAS -Mutant Cancers
- (2017) Andrew J. Aguirre et al. Cold Spring Harbor Perspectives in Medicine
- Renal Medullary Carcinoma: Establishing Standards in Practice
- (2017) Kathryn E. Beckermann et al. Journal of Oncology Practice
- MUC1-C drives MYC in multiple myeloma
- (2016) Ashujit Tagde et al. BLOOD
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
- (2016) Jonathon Torchia et al. CANCER CELL
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- (2016) Pascal D. Johann et al. CANCER CELL
- Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
- (2016) Hye-Jung E. Chun et al. CANCER CELL
- Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
- (2016) Julien Calderaro et al. EUROPEAN UROLOGY
- International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
- (2016) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
- (2016) Xiaofeng Wang et al. NATURE GENETICS
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated genetic and pharmacologic interrogation of rare cancers
- (2016) Andrew L. Hong et al. Nature Communications
- The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
- (2016) Zhi-Yan Han et al. Nature Communications
- Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells
- (2016) Juan J. Gu et al. Oncotarget
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species
- (2015) J. S. Garcia et al. CLINICAL CANCER RESEARCH
- Clinical outcome and prognostic factors in renal medullary carcinoma. A pooled analysis from 18 years of medical literature.
- (2015) Roberto Iacovelli et al. CUAJ-Canadian Urological Association Journal
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- Renal medullary carcinoma and sickle cell trait: A systematic review
- (2015) Ofelia Alvarez et al. PEDIATRIC BLOOD & CANCER
- The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis
- (2015) Mark D. Allen et al. STRUCTURE
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- The Proteasome Distinguishes between Heterotypic and Homotypic Lysine-11-Linked Polyubiquitin Chains
- (2015) Guinevere L. Grice et al. Cell Reports
- KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism
- (2015) Nibedita Chattopadhyay et al. PLoS One
- Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
- (2014) Katherine C. Helming et al. CANCER CELL
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models
- (2014) L J Crawford et al. Oncogenesis
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib
- (2013) Tamer B. Shabaneh et al. PLoS One
- Characterization of DNA Binding Property of the HIV-1 Host Factor and Tumor Suppressor Protein Integrase Interactor 1 (INI1/hSNF5)
- (2013) Supratik Das et al. PLoS One
- A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
- (2012) Ryan S. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1
- (2012) Nevena V. Dimova et al. NATURE CELL BIOLOGY
- Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma
- (2011) Prashant Bavi et al. AMERICAN JOURNAL OF PATHOLOGY
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
- (2011) Dharminder Chauhan et al. CLINICAL CANCER RESEARCH
- Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods
- (2011) Chao Chen et al. PLoS One
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- (2010) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior
- (2008) Jason X Cheng et al. MODERN PATHOLOGY
- Highly parallel identification of essential genes in cancer cells
- (2008) B. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search